Verastem VSTM
NASDAQ VSTM
$8.00 +0.02 (+0.25%)
As of: Sep 4, 2026 · 2:31 PM EDT

Verastem (VSTM) Shares Outstanding (2011 - 2026)

Verastem (VSTM) posted quarterly Shares Outstanding (Entity) of $87.8 million for Q1 2026, up 70.6% year-over-year from $51.5 million in Q1 2025, and up 13.0% quarter-over-quarter from $77.7 million in Q4 2025.

Analysis

Verastem (VSTM) Shares Outstanding (2011 - 2026) Analysis & Trends

Verastem's Shares Outstanding (Entity) history runs 16 years deep, the most recent figure standing at $87.8 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Entity) rose 70.6% year-over-year to $87.8 million; the TTM figure through Mar 2026 stood at $87.8 million (up 70.6% YoY), while the FY2025 annual figure was $77.7 million, up 117.68% from the prior year.
  • Shares Outstanding (Entity) for Q1 2026 stood at $87.8 million, up from $77.7 million in the prior quarter.
  • The five-year high for Shares Outstanding (Entity) was $87.8 million in Q1 2026, with the low at $15.5 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Entity) is $25.3 million (2024), against an average of $36.7 million.
  • The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) increased 7.79% in 2023, then soared 128.91% in 2025.
  • Verastem's Shares Outstanding (Entity) stood at $16.7 million in 2022, then soared by 51.28% to $25.3 million in 2023, then surged by 41.26% to $35.7 million in 2024, then soared by 117.68% to $77.7 million in 2025, then grew by 13.0% to $87.8 million in 2026.
  • Business Quant data shows VSTM's Shares Outstanding (Entity) at $87.8 million in Q1 2026, $77.7 million in Q4 2025, and $66.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 61.30 Mn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - 210.89 Mn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 111.58 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 133.61 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn - 445.06 Mn
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn 217.35 Mn
10 Verastem 800.93 Mn 664.58 Mn 36.32 Mn 100.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100.12 Mn
Mar 31, 2026 98.29 Mn
Dec 31, 2025 69.31 Mn
Sep 30, 2025 73.16 Mn
Jun 30, 2025 66.14 Mn
Mar 31, 2025 54.17 Mn
Dec 31, 2024 35.71 Mn
Sep 30, 2024 40.26 Mn
Jun 30, 2024 26.86 Mn
Mar 31, 2024 26.83 Mn
Dec 31, 2023 22.05 Mn
Sep 30, 2023 26.79 Mn
Jun 30, 2023 17.73 Mn
Mar 31, 2023 16.72 Mn
Dec 31, 2022 16.14 Mn
Sep 30, 2022 16.43 Mn
Jun 30, 2022 15.54 Mn
Mar 31, 2022 15.52 Mn
Dec 31, 2021 14.53 Mn
Sep 30, 2021 14.99 Mn